Dr Reddys (Germany) Today
| RDDA Stock | EUR 13.40 0.20 1.52% |
Performance0 of 100
| Odds Of DistressLess than 9
|
Dr Reddys is trading at 13.40 as of the 27th of November 2024. This is a 1.52 percent increase since the beginning of the trading day. The stock's lowest day price was 13.4. Dr Reddys has less than a 9 % chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days.Dr Reddys has reported 1 for 5 split on 5th of November 2024. Equity ratings for Dr Reddys Laboratories are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 29th of August 2024 and ending today, the 27th of November 2024. Click here to learn more.
Reddys Laboratories Limited operates as an integrated pharmaceutical company worldwide. Reddys Laboratories Limited was founded in 1984 and is headquartered in Hyderabad, India. DR REDDYS operates under Drug Manufacturers - Specialty Generic classification in Germany and is traded on Frankfurt Stock Exchange. The company has 166.1 M outstanding shares. More on Dr Reddys Laboratories
Moving against RDDA Stock
RDDA Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Dr Reddys' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Dr Reddys or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Drug Manufacturers - Specialty & Generic, Healthcare (View all Sectors) |
Dr Reddys Laboratories (RDDA) is traded on Frankfurt Exchange in Germany and employs 24,795 people. The company currently falls under 'Mid-Cap' category with a current market capitalization of 8.14 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Dr Reddys's market, we take the total number of its shares issued and multiply it by Dr Reddys's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Dr Reddys Laboratories operates under Healthcare sector and is part of Drug Manufacturers - Specialty & Generic industry. The entity has 166.1 M outstanding shares.
Dr Reddys Laboratories has accumulated about 306.55 M in cash with 28.11 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.85.
Check Dr Reddys Probability Of Bankruptcy
Ownership AllocationDr Reddys Laboratories secures a total of 166.1 Million outstanding shares. About 89.63 % of Dr Reddys outstanding shares are held by general public with 10.37 (percent) by institutions. Please note that no matter how many assets the company retains, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check RDDA Ownership Details
Dr Reddys Laboratories Risk Profiles
Although Dr Reddys' alpha and beta are two of the key measurements used to evaluate Dr Reddys' performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 1.2 | |||
| Standard Deviation | 1.53 | |||
| Variance | 2.34 | |||
| Risk Adjusted Performance | (0.05) |
RDDA Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Dr Reddys without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Portfolio Analyzer Now
Portfolio AnalyzerPortfolio analysis module that provides access to portfolio diagnostics and optimization engine |
| All Next | Launch Module |
Dr Reddys Corporate Management
Elected by the shareholders, the Dr Reddys' board of directors comprises two types of representatives: Dr Reddys inside directors who are chosen from within the company, and outside directors, selected externally and held independent of RDDA. The board's role is to monitor Dr Reddys' management team and ensure that shareholders' interests are well served. Dr Reddys' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Dr Reddys' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Parag Agarwal | CFO Council | Profile | |
| Sanjay BTech | Global VP | Profile | |
| Erez MBA | CEO Council | Profile | |
| Gunupati BE | MD CoChairman | Profile | |
| MS BTech | Chairman Council | Profile | |
| MBA MBA | CEO Council | Profile | |
| Deepak MBA | CEO Council | Profile |
Additional Information and Resources on Investing in RDDA Stock
When determining whether Dr Reddys Laboratories offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Dr Reddys' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Dr Reddys Laboratories Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Dr Reddys Laboratories Stock:Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Dr Reddys Laboratories. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.